Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model

被引：0
|
作者：
Zhang, Ranran [1 ,2 ]
Janardhanan, Yashaswini [2 ]
Haldar, Rohit [2 ]
Cooper, Leanne [2 ]
Jaquelin, Sebastien [1 ]
Straube, Jasmin [2 ]
Bywater, Megan [1 ,2 ]
Lane, Steven W. [2 ,3 ,4 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Canc Program, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Canc Care Serv, Herston, Qld, Australia
[4] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
    Jamieson, CHM
    Gotlib, J
    Durocher, JA
    Chao, MP
    Mariappan, MR
    Lay, M
    Jones, C
    Zehnder, JL
    Lilleberg, SL
    Weissman, IL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) : 6224 - 6229
  • [42] Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
    Mullally, Ann
    Lane, Steven W.
    Ball, Brian
    Megerdichian, Christine
    Okabe, Rachel
    Al-Shahrour, Fatima
    Paktinat, Mahnaz
    Haydu, J. Erika
    Housman, Elizabeth
    Lord, Allegra M.
    Wernig, Gerlinde
    Kharas, Michael G.
    Mercher, Thomas
    Kutok, Jeffery L.
    Gilliland, D. Gary
    Ebert, Benjamin L.
    CANCER CELL, 2010, 17 (06) : 584 - 596
  • [43] Tet2 Loss Accelerates The Myeloproliferative Neoplasm (MPN) Phenotype Of Jak2V617F Knockin Mice But Is Insufficient To Cause Leukemic Transformation
    Chen, Edwin
    Breyfogle, Lawrence J.
    Schneider, Rebekka K.
    Poveromo, Luke
    Levine, Ross L.
    Ebert, Benjamin L.
    Mullally, Ann
    BLOOD, 2013, 122 (21) : 4095 - 4097
  • [44] Combined Inhibition of JAK2 and mTOR Signaling Results in Enhanced Efficacy in in-Vitro and Preclinical Mouse Models of JAK2V617F-Driven Myeloproliferative Disease
    Vannucchi, Alessandro M.
    Bartalucci, Niccolo
    Bogani, Costanza
    Martinelli, Serena
    Tozzi, Lorenzo
    Bosi, Alberto
    Villeval, Jean-Luc
    BLOOD, 2012, 120 (21)
  • [45] The JAK2 V617F mutation is present in a minority of human hematopoietic stem cells from patients with myeloproliferative disorders and does not modify their self-renewal properties
    James, C.
    Mazurier, F.
    Chaligne, R.
    Lamrissi-Garcia, I.
    Dupont, S.
    Giraudier, S.
    Delhommeau, F.
    Lippert, E.
    Mahon, E. X.
    Pasquet, J. M.
    De Verneuil, H.
    Vainchenker, W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 164 - 165
  • [46] Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells
    Mansier, Olivier
    Kilani, Badr
    Guitart, Amelie V.
    Guy, Alexandre
    Gourdou-Latyszenok, Virginie
    Marty, Caroline
    Parrens, Marie
    Plo, Isabelle
    Vainchenker, William
    James, Chloe
    BLOOD, 2019, 134 (26) : 2383 - 2387
  • [47] Single Cell Analysis Of JAK2V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation
    Gerber, Jonathan M.
    Williams, Donna M.
    Rogers, Ophelia
    Morse, Sarah
    Zhang, Hao
    McDevitt, Michael A.
    Jones, Richard J.
    Spivak, Jerry L.
    Moliterno, Alison R.
    BLOOD, 2013, 122 (21)
  • [48] JAK2 V617F quantitation versus donor chimerism to monitor engraftment kinetics post-allogeneic haematopoietic stem cell transplantation for myeloproliferative neoplasms
    Haslam, K.
    Molloy, K. M.
    Conneally, E.
    Langabeer, S. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 61 - 62
  • [49] Modeling JAK2V617F Heterozygous and Homozygous Mutations by Using Induced Pluripotent Stem Cells Derived From Myeloproliferative Neoplasms Patients
    Saliba, Joseph
    Hamidi, Sofiane
    Di Stefano, Antonio
    Langlois, Thierry
    Lenglet, Gaelle
    Secardin, Lise
    Galy, Anne
    Opolon, Paule
    Debili, Najet
    Raslova, Hana
    Norol, Francoise
    Plo, Isabelle
    Vainchenker, William
    BLOOD, 2012, 120 (21)
  • [50] JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse
    Lange, Thoralf
    Edelmann, Anja
    Siebolts, Udo
    Krahl, Rainer
    Nehring, Claudia
    Jakel, Nadja
    Cross, Michael
    Maier, Jacqueline
    Niederwieser, Dietger
    Wickenhauser, Claudia
    HAEMATOLOGICA, 2013, 98 (05) : 722 - 728
12345